The first Comprehensive Immune Profiling test designed to help oncologists select the best mono and combination immunotherapy options for their patients.

Peer-reviewed literature demonstrates the need to answer the following critical questions:

  1. Can the tumor be recognized as “non-self” by the immune system?
  2. Is the immune response inflamed or suppressed?
  3. Are the immune cells exhausted or hyper-exhausted?
  4. Is the tumor immune excluded?

The peer-reviewed literature would support that additional biomarkers influence the response to CPIs:

Only Immune Report Card is designed to provide all the relevant information for clinicians to choose appropriate immunotherapies with an emphasis on checkpoint inhibitors

To learn more about Immune Report Card, visit immunereportcard.com or call (800) 781-1259.